Dr. Hany Elmariah, MD

Dr. Elmariah practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Elmariah's NPI, 1427348044, was assigned on April 15, 2011. Dr. Elmariah graduated from University Of Florida College Of Medicine in 2011. Dr. Elmariah holds California license C200202.

Dr. Elmariah's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Elmariah's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Elmariah is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Elmariah to 1 more hospital and 1 medical group, each named with a free account. Dr. Elmariah's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elmariah practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Elmariah's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Elmariah is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Elmariah's licenses on file in 4 states: California, Florida, Maryland and North Carolina.

Dmand AI lists anemia and multiple myeloma among the conditions Dr. Elmariah treats.

CMS data shows 161 Medicare services from Dr. Elmariah across 3 procedure codes in 2024, for 68 Medicare patients. Medicare paid $10,722 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Elmariah in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 5.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elmariah's median patient age at 61, with 41% women.

In 2024, Dr. Elmariah wrote 663 Medicare Part D claims for 72 patients. 90% of them were for generic drugs. CMS names the drug for 409 of them, across 11 drugs with 11 or more claims each, at $454,979 in total drug cost. In 2023, CMS named 472 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Elmariah for performance year 2024, reported as part of a group. Dr. Elmariah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elmariah as offering telehealth.

Dmand AI links 45 papers to Dr. Elmariah, published from 2009 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Graft vs Host Disease, Hematopoietic Stem Cell Transplantation and Cyclophosphamide. Dr. Elmariah has published most often in Transplant Cell Ther. Dr. Elmariah's most frequent co-authors are Taiga Nishihori, MD, Nelli Bejanyan, MD and Rawan G. Faramand, MD.

Dmand AI links Dr. Elmariah to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Leukemia, Prolymphocytic, Myelodysplastic Syndromes and Bone Marrow Diseases. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 2.

CMS Open Payments shows 5 general payments to Dr. Elmariah from 4 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 93% of the total. Sobi, Inc paid the most, $3,850.

Dr. Elmariah graduated from University Of Florida College Of Medicine in 2011.

Dr. Elmariah is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.